Month: September 2021

Golden Ocean Group Limited (Nasdaq and OSE: GOGL) (“Golden Ocean” or the “Company”), one of the world’s largest listed dry bulk shipowners, today announces that it has entered into an agreement for the construction of three high-specification latest generation 85,000 dwt ECO-type Kamsarmax vessels, which will be constructed at a first-class Chinese yard. The vessels will be equipped with the latest and most efficient propulsion system, contributing with significant improvements in fuel consumption and emissions performance. The vessels are dual-fuel ready, giving the Company time to evaluate alternatives while the visibility of future regulations and optimal technology improves. The vessels are scheduled to deliver from Q3–2023 to Q1-2024. Golden Ocean intends to finance the acquisition with operating cash...

Capelle aan den IJssel, the Netherlands, 9 September 2021: While GeoJunxion’s business continues to show strong resilience and improved performance as well as a very encouraging YoY topline growth during H1 2021, we regret to communicate that, in spite of very extensive efforts, it has not been possible to contract a PIE/OOB-licensed auditor for the audit of our June 2020/21 Consolidated Financial Statements. The Company will therefore be forced to publish its Consolidated Financial Statements without an auditor’s opinion. The Supervisory and Management Board regret this outcome and want to stress that the reasons and considerations of the audit firms not to serve the Company are completely outside of their control.  In fact, they find the root cause in the strict application of the legislation for PIEs/OOBs, as well as in the apparent...

STOCKHOLM, SWEDEN – September 9, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the portfolio company OssDsign AB has included the first patient to the clinical trial TOP FUSION which aims to evaluate the long-term safety and efficacy of the synthetic bone graft OssDsign Catalyst in patients undergoing spinal fusion surgery. The clinical trial will run for 24 months and include 17 patients suffering from degenerative disc disease, degenerative spondylolisthesis or lumbar spinal stenosis. TOP FUSION is being conducted primarily to evaluate the safety and efficacy of OssDsign Catalyst in patients undergoing spinal fusion surgery. Study outcomes are based primarily on the degree of fusion between the vertebrae and the incidence of treatment-related adverse events. The innovative bone graft consists of a patented...

Market development Strategic cooperation between Feintool and SITEC in China The two technology companies have signed a Memorandum of Understanding. They will collaborate on the metallic bipolar plates production for fuel cells in China. The market for hydrogen and fuel cell applications in China is developing extremely dynamically and offers a high potential. In order to produce metallic bipolar plates – the core of a fuel cell – economically and on an industrial scale – the forming and joining process needs to meet highest requirements in terms of tightness, precision and repeatability. With the “FEINforming” process developed by Feintool, the group intends to take off not only in Europe but also in China. Together with laser specialist SITEC, the first step in the collaboration will be to set up equipment...

NRD Cyber Security, a cyber security consultancy and technology development company, generated revenues of EUR 1,979 million in the first half of 2021, an increase of 106% compared to revenues of EUR 962,000 in the first half of 2020. According to unaudited data, the company’s EBITDA in the first six months amounted to EUR 534,000, a 13-fold increase on the first half of 2020.      In the first half of this year, NRD Cyber Security made a net profit of EUR 432,000, while in the same period of 2020 sustained a net loss of EUR 57,000. In total, NRD Cyber Security had projects in 36 countries around the world in the first half of 2021. Compared to the previous year, the share of NRD Cyber Security’s revenues coming from the financial and private sectors grew significantly in the first half of 2021, i.e., 50% of the first half...

Roche to acquire the TIB Molbiol Group with the expectation to close in fourth quarter of 2021 TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemic The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche`s LightCycler PCR instrumentsBasel, 09 September 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has signed a definitive share purchase agreement to acquire 100% of the outstanding shares of the TIB Molbiol Group. Closing of the transaction is subject to customary conditions and is expected in the fourth quarter of 2021. The acquisition of the TIB Molbiol Group will enhance Roche’s broad portfolio of molecular diagnostics solutions with a wide...

Sanofi provides update on Phase 3 study evaluating rilzabrutinib for the treatment of pemphigus PARIS – September 9, 2021 – The Phase 3 PEGASUS trial evaluating rilzabrutinib to treat pemphigus, a rare autoimmune skin condition, did not meet its primary or key secondary endpoints. Rilzabrutinib’s safety profile remained consistent with previous results and no new safety signals were identified. The Phase 3 study, which is the first placebo-controlled trial of a BTK inhibitor in pemphigus, enrolled adult patients with moderate-to-severe pemphigus vulgaris or pemphigus foliaceus. The primary endpoint was complete remission from weeks 29 to 37 with minimal doses of corticosteroids (≤10/mg day). Complete remission was defined as the absence of new and established skin lesions. Results show the proportion of patients meeting the primary endpoint...

WISeKey and FOSSA Systems present WISeSat at The International Cybersecurity Forum (FIC) for delivering secure and global, satellite IoT connectivity WISeSat will offer secure and cost-effective IoT connectivity for any sector (agrotech, energy, logistics, IIoT, climate change monitoring, etc.) everywhere on the planetGeneva, Switzerland – September 9, 2021: WISeKey International Holding Ltd (“WISeKey “) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, AI, Blockchain and IoT company, and FOSSA Systems, a Spanish-based leading aerospace company focused on developing picosatellites for IoT communications, presented at FIC 2021 in Lille, France, the WISeSat, a PocketQube satellite that enables IoT connectivity, encrypted and dedicated with WISeKey’s secure module VaultIC®. WISeSat is the first cost-effective and secure IoT...

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 9 September 2021 Disclosure of received notification of FMR LLC Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received a notification of FMR LLC. Notification of FMR LLCOn 3 September 2021, Fagron received a notification that the shareholding of FMR LLC had crossed the disclosure threshold of 3% on 2 September 2021 as the result of the acquisition of voting securities or voting rights. The notification is made by a ‘parent undertaking or a controlling person’. On 2 September 2021, FMR LLC held a total of 2,437,520 voting rights. 1,253,700 voting rights are held by Fidelity Management & Research Company LLC, 573,208 voting rights are held by FMR Investment Management (UK) Limited, 465,190 shares...